Filed March 6, 2020

Serial No. 88824805

Examining Attorney TRICIA L SONNEBORN

Class Pharmaceutical preparations, including, beta-Hydroxy beta-methylglutaryl-CoA (HMG-CoA) reductase inhibitors; cholesterol lowering medications; pharmaceutical preparations that act on the central nervous system; neuromodulators; pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); liquid oral preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); solid preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); pharmaceutical preparations for the treatment of narcolepsy; pharmaceutical preparations for the treatment of chronic lung disease; pharmaceutical preparations for the treatment of colds; pharmaceutical preparations for the treatment of coughs; extended release liquid for the treatment of coughs; pharmaceutical preparations for the treatment of upper respiratory symptoms; pharmaceutical preparations for the treatment of pain; 006; 018; 044; 046; 051; 052; 100; 101